160 related articles for article (PubMed ID: 26157319)
1. Prediction of radiosensitivity in primary central nervous system germ cell tumors using dynamic contrast-enhanced magnetic resonance imaging.
Feng C; Gao P; Qiu X; Qian T; Lin Y; Zhou J; Sui B
Chin J Cancer Res; 2015 Jun; 27(3):231-8. PubMed ID: 26157319
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
Guo W; Zhang Y; Luo D; Yuan H
Br J Radiol; 2020 Nov; 93(1115):20200751. PubMed ID: 32915647
[No Abstract] [Full Text] [Related]
3. Role of dynamic contrast-enhanced MRI in predicting severe acute radiation-induced rectal injury in patients with rectal cancer.
Chen Y; Ding L; Zhang ZW; Wu XH; Que YT; Ma YR; Liu YY; Wen ZQ; Yang XY; Lu BL; Bao Y; Niu SQ; Yu SP
Eur Radiol; 2024 Mar; 34(3):1471-1480. PubMed ID: 37665390
[TBL] [Abstract][Full Text] [Related]
4. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer.
Wang W; Lv S; Xun J; Wang L; Zhao F; Wang J; Zhou Z; Chen Y; Sun Z; Zhu L
Eur J Radiol; 2022 Sep; 154():110392. PubMed ID: 35679701
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic analysis for the differentiation of pituitary microadenoma subtypes through dynamic contrast-enhanced magnetic resonance imaging.
Zhai J; Zheng W; Zhang Q; Wu J; Zhang X
Oncol Lett; 2019 May; 17(5):4237-4244. PubMed ID: 30944618
[TBL] [Abstract][Full Text] [Related]
6. The Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Predicting Treatment Response for Cervical Cancer Treated with Concurrent Chemoradiotherapy.
Lu H; Wu Y; Liu X; Huang H; Jiang H; Zhu C; Man Y; Liu P; Li X; Chen Z; Long X; Pang Q; Deng S; Gu J
Cancer Manag Res; 2021; 13():6065-6078. PubMed ID: 34377025
[TBL] [Abstract][Full Text] [Related]
7. [Feasibility study of dynamic contrast enhanced magnetic resonance imaging qualitative diagnosis of musculoskeletal tumors].
Zhang J; Zuo PL; Cheng KB; Yu AH; Cheng XG
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 48(2):287-91. PubMed ID: 27080283
[TBL] [Abstract][Full Text] [Related]
8. Extracellular volume fraction with MRI: As an alternative predictive biomarker to dynamic contrast-enhanced MRI for chemotherapy response of pancreatic ductal adenocarcinoma.
Fukukura Y; Kumagae Y; Fujisaki Y; Nakamura S; Dominik Nickel M; Imai H; Yoshiura T
Eur J Radiol; 2021 Dec; 145():110036. PubMed ID: 34814039
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and value of quantitative dynamic contrast enhancement MR imaging in the evaluation of sinonasal tumors.
Xian J; Du H; Wang X; Yan F; Zhang Z; Hao H; Zhao B; Tong Y; Zhang J; Han D
Chin Med J (Engl); 2014; 127(12):2259-64. PubMed ID: 24931238
[TBL] [Abstract][Full Text] [Related]
10. Soft tissue sarcoma: correlation of dynamic contrast-enhanced magnetic resonance imaging features with HIF-1α expression and patient outcomes.
Li X; Xie Y; Hu Y; Lu R; Li Q; Xiong B; Tao H; Chen S
Quant Imaging Med Surg; 2022 Oct; 12(10):4823-4836. PubMed ID: 36185052
[TBL] [Abstract][Full Text] [Related]
11. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor.
Lu S; Gao Q; Yu J; Li Y; Cao P; Shi H; Hong X
Eur J Radiol; 2016 Oct; 85(10):1722-1727. PubMed ID: 27666608
[TBL] [Abstract][Full Text] [Related]
12. Grading of pancreatic neuroendocrine neoplasms using pharmacokinetic parameters derived from dynamic contrast-enhanced MRI.
Zhao W; Quan Z; Huang X; Ren J; Wen D; Zhang G; Shi Z; Yin H; Huan Y
Oncol Lett; 2018 Jun; 15(6):8349-8356. PubMed ID: 29805568
[TBL] [Abstract][Full Text] [Related]
13. Assessment of esophageal carcinoma undergoing concurrent chemoradiotherapy with quantitative dynamic contrast-enhanced magnetic resonance imaging.
Lei J; Han Q; Zhu S; Shi D; Dou S; Su Z; Xu X
Oncol Lett; 2015 Dec; 10(6):3607-3612. PubMed ID: 26788177
[TBL] [Abstract][Full Text] [Related]
14. Injection rate of contrast medium affects diagnostic ability of dynamic contrast-enhanced magnetic resonance imaging for endometrial carcinoma: a prospective cohort study.
Xu D; Jin A; Ge Y; Zhang Y
Gland Surg; 2021 Aug; 10(8):2462-2470. PubMed ID: 34527558
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of permeability for glioma grading using dynamic contrast-enhanced magnetic resonance imaging.
Zhao M; Guo LL; Huang N; Wu Q; Zhou L; Zhao H; Zhang J; Fu K
Oncol Lett; 2017 Nov; 14(5):5418-5426. PubMed ID: 29113174
[TBL] [Abstract][Full Text] [Related]
16. Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI.
Guo P; Liu Z; Yan F; Wang J; Wei L; Lv H; Wang Z; Xian J
Acta Radiol; 2016 Dec; 57(12):1490-1496. PubMed ID: 27012277
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults.
Oh E; Yoon YC; Kim JH; Kim K
Clin Radiol; 2017 Jul; 72(7):552-559. PubMed ID: 28325514
[TBL] [Abstract][Full Text] [Related]
18. DCE-MRI Quantitative Parameters as Predictors of Treatment Response in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Underwent CCRT.
Liu B; Sun Z; Ma WL; Ren J; Zhang GW; Wei MQ; Hou WH; Hou BX; Wei LC; Huan Y; Zheng MW
Front Oncol; 2020; 10():585738. PubMed ID: 33194734
[TBL] [Abstract][Full Text] [Related]
19. [The value of DCE-MRI in predicting IDH gene mutation of high-grade gliomas].
Lu HT; Xing W; Zhang YW; Qin HP; Wu RH; Ding JL
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(39):3105-3109. PubMed ID: 31648456
[No Abstract] [Full Text] [Related]
20. Quantitative dynamic contrast-enhanced magnetic resonance imaging in a VX2 rabbit liver tumour model using different gadolinium-based contrast agents: comparison of DCE-MRI quantitative results between Magnevist and Eovist.
Zhang Y; Liu H; Xiao W; Zhu L; Wang N; He X; Jiang Z; Guan B
BJR Case Rep; 2017; 3(3):20160099. PubMed ID: 30363268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]